Longevity Health Holdings (XAGE) Stock Price & Analysis
XAGE Stock Chart & Stats
$0.11-$0.00(-0.09%)
At close: 11:14 AM EST
- Day’s Range
- $0.11 - $0.11
- 52-Week Range
- $0.11 - $0.67
- Previous Close
- $0.11
- Volume
- N/A
- Average Volume (3M)
- 1,786
- Market Cap
- $275.01K
- Enterprise Value
- $513.17B
- Total Cash (Recent Filing)
- $35.47K
- Total Debt (Recent Filing)
- $321.94K
- Price to Earnings (P/E)
- ―
- Beta
- 0.75
- Next Earnings
- N/A
- EPS Estimate
- N/A
- Next Dividend Ex-Date
- N/A
- Dividend Yield
- N/A
Longevity Health Holdings News
XAGE FAQ
What was Longevity Health Holdings’s price range in the past 12 months?
Longevity Health Holdings lowest stock price was $0.11 and its highest was $0.67 in the past 12 months.
What is Longevity Health Holdings’s market cap?
Longevity Health Holdings’s market cap is $275.01K.
When is Longevity Health Holdings’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
Is Longevity Health Holdings overvalued?
Not enough analysts have published a price target to calculate whether the price is overvalued.
Does Longevity Health Holdings pay dividends?
Longevity Health Holdings does not currently pay dividends.
What is Longevity Health Holdings’s EPS estimate?
Longevity Health Holdings’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Longevity Health Holdings have?
Longevity Health Holdings has 2,475,321 shares outstanding.
Which hedge fund is a major shareholder of Longevity Health Holdings?
Hedge funds hold Longevity Health Holdings shares: the largest hedge-fund position in Longevity Health Holdings is 71,872,510 shares, and hedge funds decreased their holdings by 1.1K shares last quarter.
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Longevity Health Holdings
Longevity Health Holdings Inc. specializes in creating plasma-based bioactive materials (PBMs) aimed at fostering tissue regeneration and repair in response to injury, illness, and the natural aging process. The company's primary investigational product is CT-101, which acts as a powerful accelerant for bone healing in diverse applications such as tibia fracture recovery, foot/ankle and spinal fusions, serving as a dental bone graft substitute, and filling bone voids. Additionally, CT-101 functions as a tissue healing accelerant, offering potential for treating androgenetic alopecia and persistent chronic wounds. Established in 2008, the company maintains its headquarters in Pittsburgh, Pennsylvania.
- Sector
- Consumerdefensive
- Industry
- Household & Personal Products
- CEO
- Janakiram Ajjarapu
- Employees
- 10
- Website
- healthxage.com
- Address
- 2403 Sidney Street, Pittsburgh, PA, 15203, US
Technical Analysis
Overall Consensus
| Indicator | Bullish | Neutral | Bearish |
|---|---|---|---|
| Overall Consensus | 5 | 2 | 14 |
| Technical Analysis | 4 | 2 | 3 |
| Moving Averages | 1 | 0 | 11 |
